Impacts to Anxiety, Depression, and Psycho-Spiritual Metrics after Ketamine-Assisted Psychotherapy in Palliative Care Patients at the AIMS Institute

Date of Award

2024

Document Type

Project

College/School

College of Nursing

Degree Name

Doctor of Nursing Practice (DNP)

Project Mentor

Therry Rose Eparwa

Readers

Conor Watters

Abstract

There is considerable evidence that palliative care patients disproportionately experience anxiety, depression, and existential distress related to their chronic illnesses. Additionally, conventional therapies tend to be less effective in the treatment of this patient population. As such, research is being conducted into novel therapies. One of the promising therapies currently under active investigation is ketamine-assisted psychotherapy (KAP) which involves a combination of the administration of the dissociative anesthetic ketamine combined with psychotherapy.

Two clinical trials are being conducted at the Advanced Integrative Medical Sciences (AIMS) Institute in Seattle, WA, the purposes of which are to evaluate integrative care for patients with cancer and/or chronic medical conditions. A subset of the clinical trial participants were selected based upon palliative care criteria and their KAP-related data extracted for analysis. The study described herein used that data to assess the efficacy of KAP in ameliorating anxiety, depression, and psycho-spiritual distress experienced by participants as a consequence of their chronic medical conditions.

The results showed that, following an initial KAP session, there were downward shifts in anxiety and depression as indicated by changes in score on the PHQ-9 and GAD-7 survey instruments. These shifts were moderate in size, with a z(27) = -2.75, 90.3% CI = [-6, 0] point shift in the PHQ-9 score and a z(27) = -4.25, 90.3% CI = [-1, -7] point shift in the GAD-7 score, respectively. They were statistically significant at a fixed analysis effects size value of 0.6 with p-values of 0.033 and 0.011. The NIH-HEALS data showed smaller shifts (z(24) = 3.25, 88.6% CI = [-2, 8]) that were not statistically significant at an effects size of 0.6 and p-value of 0.363. Analysis was also conducted to see if participants’ ACES and Resiliency scores were correlated with changes in the aforementioned instrument scores. Correlation was rejected at a statistically significant level for either ACEs or Resiliency scores for any of the survey instruments.

Caution should be used in interpreting these results, as sample sizes were relatively small and there were significant integrative therapy-based covariates that were not addressed in the analysis, thus precluding any attribution of causality to KAP.

Latest Blog Posts

Stellate Ganglion Block Effectiveness for PTSD, Anxiety, and Depression in Psychiatric Outpatients: A Retrospective Analysis

Stellate Ganglion Block Effectiveness for PTSD, Anxiety, and Depression in Psychiatric Outpatients: A Retrospective Analysis

https://scholarworks.seattleu.edu/dnp-projects/166/ The prevalences of Post-Traumatic Stress Disorder (PTSD), generalized anxiety disorder (GAD), and major depressive disorder (MDD) have risen significantly in recent years, particularly following the COVID-19 pandemic. Many individuals remain symptomatic despite conventional treatments, highlighting the need for novel, integrative interventions. Stellate Ganglion Block (SGB), a procedure targeting the cervical sympathetic chain to modulate the autonomic nervous system, has emerged as a promising therapy for treatment-resistant psychiatric symptoms. Evaluating data from the PTSD Checklist for DSM-5 (PCL-5), Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9), this retrospective study examined the clinical outcomes of PTSD, anxiety, and depression symptoms ...

Read More
BEWARE OF CANCER MISINFORMATION

BEWARE OF CANCER MISINFORMATION

Our AIMS Institute oncology team is well informed about alternative cancer therapies such as ivermectin, intravenous vitamin C, mistletoe, curcumin, and mebendazole.  We help our patients sort through marketing hype, wishful thinking, and the real value of some alternative treatments. We say to our cancer patients who do not trust conventional medicine to beware of misinformation on the internet.  Be discerning.  We can help. Here is a recent MEDSCAPE article on this topic. ...

Read More
AIMS INSTITUTE’S COGNITIVE DECLINE PROTOCOL

AIMS INSTITUTE’S COGNITIVE DECLINE PROTOCOL

LJ STANDISH AND DAVID JAMES Dr. Standish and her team can help improve brain function, improve memory and slow cognitive decline in Alzheimer’s disease.  Please make an appointment to start.  Call 206-420-1321.  Scientific Rationale A protocol incorporating low-dose lithium orotate, Lion’s Mane mushroom extract, NADH, transcranial magnetic stimulation (TMS), and blood sugar regulation counseling is scientifically rational for treating cognitive decline based on mechanistic, preclinical, and emerging human studies. Low-Dose Lithium Orotate (5 mg/day) Recent brain tissue studies link low brain lithium to the onset and progression of Alzheimer’s disease, with deficiency accelerating synaptic loss and cognitive decline. Low-dose lithium orotate has ...

Read More
Call Us Text Us
Skip to content